Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4Q93

Crystal structure of resveratrol bound human tyrosyl tRNA synthetase

Summary for 4Q93
Entry DOI10.2210/pdb4q93/pdb
Related1N3L 1Q11 4QBT
DescriptorTyrosine--tRNA ligase, cytoplasmic, RESVERATROL, SULFATE ION, ... (7 entities in total)
Functional Keywordsresveratrol, aminoacyl trna synthetases, amino acid activation, active site, ligase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight43347.76
Authors
Mathew, S.,Schimmel, P. (deposition date: 2014-04-28, release date: 2014-12-17, Last modification date: 2023-09-20)
Primary citationSajish, M.,Schimmel, P.
A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol.
Nature, 519:370-373, 2014
Cited by
PubMed Abstract: Resveratrol is reported to extend lifespan and provide cardio-neuro-protective, anti-diabetic, and anti-cancer effects by initiating a stress response that induces survival genes. Because human tyrosyl transfer-RNA (tRNA) synthetase (TyrRS) translocates to the nucleus under stress conditions, we considered the possibility that the tyrosine-like phenolic ring of resveratrol might fit into the active site pocket to effect a nuclear role. Here we present a 2.1 Å co-crystal structure of resveratrol bound to the active site of TyrRS. Resveratrol nullifies the catalytic activity and redirects TyrRS to a nuclear function, stimulating NAD(+)-dependent auto-poly-ADP-ribosylation of poly(ADP-ribose) polymerase 1 (PARP1). Downstream activation of key stress signalling pathways are causally connected to TyrRS-PARP1-NAD(+) collaboration. This collaboration is also demonstrated in the mouse, and is specifically blocked in vivo by a resveratrol-displacing tyrosyl adenylate analogue. In contrast to functionally diverse tRNA synthetase catalytic nulls created by alternative splicing events that ablate active sites, here a non-spliced TyrRS catalytic null reveals a new PARP1- and NAD(+)-dependent dimension to the physiological mechanism of resveratrol.
PubMed: 25533949
DOI: 10.1038/nature14028
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

247947

PDB entries from 2026-01-21

PDB statisticsPDBj update infoContact PDBjnumon